{"id":213624,"name":"STOKE THERAPEUTICS","slug":"stoke-therapeutics","state":"MA","country":"United States of America","description":"Biotechnology company.","totalSpending":120000,"filings":5,"yearlySpending":[{"year":2022,"income":120000}],"issues":["HCR"],"firms":["W STRATEGIES, LLC"],"lobbyists":["DARREN WILLCOX"],"govEntities":["HOUSE OF REPRESENTATIVES"],"sampleDescriptions":["Education around innovation in neurological rare disease.","Education around innovation in neurological rare disease. Reauthorization of the Prescription Drug Act and related issues.","Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.","Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.","Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022."],"years":[2022]}